ZOLI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 4.784
AS - Asia 3.224
EU - Europa 1.507
SA - Sud America 591
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 99
OC - Oceania 55
Totale 10.430
Nazione #
US - Stati Uniti d'America 4.602
SG - Singapore 1.073
CN - Cina 856
IT - Italia 599
BR - Brasile 466
VN - Vietnam 332
HK - Hong Kong 306
DE - Germania 189
TR - Turchia 182
UA - Ucraina 141
BD - Bangladesh 131
GB - Regno Unito 126
FR - Francia 89
CA - Canada 87
RU - Federazione Russa 82
IN - India 72
MX - Messico 66
ID - Indonesia 55
AU - Australia 53
FI - Finlandia 52
PL - Polonia 50
AR - Argentina 44
NL - Olanda 42
ZA - Sudafrica 40
JP - Giappone 39
SE - Svezia 31
IQ - Iraq 27
ES - Italia 21
EC - Ecuador 20
IR - Iran 19
PH - Filippine 17
MA - Marocco 15
CO - Colombia 14
PK - Pakistan 14
CL - Cile 12
CZ - Repubblica Ceca 12
MY - Malesia 12
UZ - Uzbekistan 12
VE - Venezuela 12
AT - Austria 11
LT - Lituania 11
NG - Nigeria 11
PY - Paraguay 11
SA - Arabia Saudita 10
IE - Irlanda 9
TW - Taiwan 9
EG - Egitto 7
JO - Giordania 7
CH - Svizzera 6
GR - Grecia 6
PE - Perù 6
TN - Tunisia 6
HU - Ungheria 5
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
NI - Nicaragua 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BE - Belgio 4
CR - Costa Rica 4
DZ - Algeria 4
HN - Honduras 4
KG - Kirghizistan 4
KR - Corea 4
LB - Libano 4
RS - Serbia 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
TH - Thailandia 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
CU - Cuba 2
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
Totale 10.253
Città #
Ashburn 770
Singapore 700
Fairfield 479
Santa Clara 375
Hong Kong 301
San Jose 284
Beijing 279
Woodbridge 211
Seattle 203
Wilmington 168
Cambridge 158
Izmir 157
Houston 156
Ho Chi Minh City 133
Council Bluffs 122
New York 95
Nanjing 78
Los Angeles 71
Dallas 70
Princeton 69
Hanoi 68
Lauterbourg 68
Milan 67
Ann Arbor 63
Jacksonville 56
Munich 54
São Paulo 53
Boardman 47
Rome 47
Mexico City 46
Bologna 40
Warsaw 40
Helsinki 34
Jakarta 34
London 33
Shanghai 32
Tokyo 32
Toronto 31
Sydney 28
Chicago 27
San Diego 27
Shenyang 26
Ferrara 25
Chandler 23
Florence 22
Atlanta 21
Bremen 20
Brooklyn 18
Nanchang 18
Orem 18
Tianjin 18
Hebei 17
Jinan 17
Montreal 17
Buffalo 16
Turin 16
Guangzhou 15
Johannesburg 15
Melbourne 15
Turku 15
Denver 14
Frankfurt am Main 14
Rio de Janeiro 14
Baghdad 13
Belo Horizonte 13
Changsha 13
Chennai 13
Haiphong 13
Imola 13
Jiaxing 13
Modena 13
Phoenix 13
Da Nang 12
Norwalk 12
Stockholm 11
Istanbul 10
Moscow 10
Nuremberg 10
Palermo 10
San Francisco 10
Verona 10
Bari 9
Durham 9
Falls Church 9
Mumbai 9
Ottawa 9
Porto Alegre 9
Brasília 8
Brno 8
Bắc Ninh 8
Dhaka 8
Fortaleza 8
Manchester 8
Mountain View 8
Quito 8
Reggio Nell'emilia 8
Taizhou 8
Tampa 8
Zhengzhou 8
Amsterdam 7
Totale 6.569
Nome #
Effects of Ethanol on the Digestive System: A Narrative Review 432
Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi [Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi] 295
Alcohol Hub: il trattamento farmacologico dei disordini da uso di alcol 292
Sindrome da astinenza protratta da alcol: il ruolo del sodio ossibato...e non solo 244
Splenic autotransplantation after splenectomy: Tuftsin activity correlates with residual splenic function 205
Randomised controlled trial of mesalazine in IBS 201
A brief up-date of the use of sodium oxybate for the treatment of alcohol use disorder 200
Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA) 198
Osteoporosis in Celiac Disease: An Update 191
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study 189
Nutritional Treatment in Crohn’s Disease 186
Cardiac involvement in Crohn's disease: Echocardiographic study 182
Effect of gluten-free diet on gut microbiota composition in patients with celiac disease and non-celiac gluten/wheat sensitivity 178
A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse 177
Beyond biologics: advanced therapies in inflammatory bowel diseases 171
Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options 167
Alcohol use in patients with chronic liver disease 165
Alcohol use disorder and GABAB receptor gene polymorphisms in an Italian sample: haplotype frequencies, linkage disequilibrium and association studies 163
Alcohol use disorders and liver fibrosis: an update 156
The course of inflammatory bowel disease during pregnancy and postpartum: A prospective European ECCO-EpiCom Study of 209 pregnant women 156
Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau 151
A reassessment of splenic hypofunction in celiac disease 150
Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA) 150
An evaluation of factors affecting helicobacter pylori prevalence in tibetans exiled in india 149
Life-threatening onset of coeliac disease: A case report and literature review 142
Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition 140
Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series 140
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity 139
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE) 139
Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review 136
Evidence-based decision for pharmacological management of alcoholic liver disease and alcohol dependence 136
Gastrointestinal involvement in anderson-fabry disease: A narrative review 135
Symptoms of protracted alcohol withdrawal in patients with alcohol use disorder: a comprehensive systematic review 134
Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls 130
Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study 130
Recurrent myocarditis in a patient with active ulcerative colitis: A case report and review of the literature 130
Efficacy and safety of capsule endoscopy in octogenarian patients: a retrospective study 127
CLINICAL APPLICATIONS OF SCANNING ELECTRON MICROSCOPY IN GASTROINTESTINAL DISEASES 126
Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: A review 126
Plasma Norepinephrine, Weak Neurotransmitters, and Renin Activity During Active Tilting in Liver Cirrhosis: Relationship with Cardiovascular Homeostasis and Renal Function 125
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence 124
Treatment of alcohol-use disorders 123
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease 122
Promotion of gallbladder emptying by intravenous aminoacids 120
Treatment of narcolepsy with cataplexy 118
Therapeutic options for coeliac disease: What else beyond gluten-free diet? 118
Changes in peripheral blood lymphocytes and immune complexes in splenectomized patients: lack of correlation with residual splenic function 117
Cytophilic antibodies cause leucocyte migration inhibition in coeliac disease 115
Subclinical coeliac disease: an anthropometric assessment 115
Il trattamento farmacologico della dipendenza da alcol 113
Defective phagocyte activity in adult coeliac disease 112
Increased resting lipid oxidation in Crohn's disease 109
Gamma hydroxybutyric acid (GHB): A valid pharmacological opportunity for the treatment of alcohol dependence 109
Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study 104
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 104
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 103
Alcohol Use in Adults Reply 100
Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy 96
Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: Partial benefit by infiximab - A pilot study 94
Increased energy expenditure in growing adolescents with Crohn's disease 94
Major gastrointestinal hemorrhage during anticoagulant therapy in patients with atrial fibrillation: When should treatment be resumed? [Emorragia gastrointestinale maggiore in corso di terapia anticoagulante nei pazienti con fibrillazione atriale: quando riprendere il trattamento? ] 93
Identification of harmful drinking in subjects who have had their driving license suspended due to alcohol use: a retrospective Italian study 92
Echocardiographic evaluation of anti-Tumor Necrosis Factor-α therapy with infliximab in patients without cardiac pathologies 91
Effect of arginine thiazolidinecarboxylate (ATCA)* * SULFILE is the trade name for arginine thiazolidinecarboxylate (200 mg vials) manufactured by Poli-Industria Chimica, Italy. on some clinical and functional parameters in cirrhotic patients 86
Tuftsin deficiency in AIDS 85
Ocular naevus and hyperaemia with dilation of the conjunctival vessels: An early manifestation of Crohn's disease? 83
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study 78
S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man 76
Ultrastructural aspects of duodenal mucosa repair during treatment of peptic disease 76
Howell‐Jolly body counting as a measure of splenic function. A reassessment 76
S.E.M. study II. Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs 75
Pseudothrombocytopenia clinical comment on 37 cases 75
Efficacy and safety of gamma-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: A case report 75
Failure of adrenergic system in the control of arterial pressure in cirrhosis. Role of weak neurotransmitters 74
Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial 72
The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder 66
Famotidine and ranitidine in the prevention of duodenal ulcer 64
Totale 10.430
Categoria #
all - tutte 59.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.521
Totale 61.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022382 0 33 4 24 10 30 24 34 16 73 18 116
2022/2023267 73 9 20 4 26 15 18 15 36 1 34 16
2023/2024387 10 19 10 18 26 15 6 15 10 17 44 197
2024/20251.774 57 92 170 97 210 207 37 68 185 321 172 158
2025/20264.802 372 223 464 663 702 266 466 318 392 499 233 204
2026/2027495 297 198 0 0 0 0 0 0 0 0 0 0
Totale 10.430